NCT00433407: T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors |
|
|
| Completed | N/A | 12 | US | trastuzumab | Jonsson Comprehensive Cancer Center, National Cancer Institute (NCI) | Breast Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific | 02/06 | | | |
NCT00847366: Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma |
|
|
| Completed | N/A | 10 | NA | Perifosine, D-21266, KRX-0401, Trastuzumab, Tamoxifen | AEterna Zentaris | Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, Sarcomas | 12/12 | 12/12 | | |
